Costs and infant outcomes after implementation of a care process model for febrile infants. - Wikidata - wikimedia - TriplyDB

Costs and infant outcomes after implementation of a care process model for febrile infants.

Costs and infant outcomes after implementation of a care process model for febrile infants.

http://www.wikidata.org/entity/Q33819465

about

Proposal of a linear rather than hierarchical evaluation of educational initiatives: the 7Is framework MLBCD: a machine learning tool for big clinical data PredicT-ML: a tool for automating machine learning model building with big clinical data.Dipstick screening for urinary tract infection in febrile infants.The future possibilities of diagnostic testing for the evaluation of febrile infants.Association of clinical practice guidelines with emergency department management of febrile infants ≤56 days of age.Using Computational Approaches to Improve Risk-Stratified Patient Management: Rationale and Methods.Cerebrospinal fluid pleocytosis in febrile infants 1-90 days with urinary tract infection.Comparison of pediatric and general emergency medicine practice patterns in infants with fever.Automating Construction of Machine Learning Models With Clinical Big Data: Proposal Rationale and Methods.Making a Case for Pediatric Antimicrobial Stewardship Programs.Burden of Healthcare-Associated Viral Respiratory Infections in Children's Hospitals.Predicting Appropriate Admission of Bronchiolitis Patients in the Emergency Department: Rationale and Methods.Facing the ongoing challenge of the febrile young infant.Iron Supplements for Infants at Risk for Iron Deficiency.Lumbar Puncture for All Febrile Infants 29-56 Days Old: A Retrospective Cohort Reassessment Study.Empiric Antibiotic Use and Susceptibility in Infants With Bacterial Infections: A Multicenter Retrospective Cohort Study.Febrile infants and children in the emergency department: Reducing fever to its simplest form.Association between Clinical Outcomes and Hospital Guidelines for Cerebrospinal Fluid Testing in Febrile Infants Aged 29-56 Days.Fever survey highlights significant variations in how infants aged ≤60 days are evaluated and underline the need for guidelines.Orthopaedic healthcare worldwide: standardized clinical assessment and management plans: an adjunct to clinical practice guidelines.Time to Positivity of Blood Cultures in Infants 0 to 90 Days Old Presenting to the Emergency Department: Is 36 Hours Enough?Incidence of Fever and Positive Bacterial Cultures in Neonates Receiving Prostaglandin.Rhinovirus in Febrile Infants and Risk of Bacterial Infection.Accuracy of the Urinalysis for Urinary Tract Infections in Febrile Infants 60 Days and Younger.To Spinal Tap or Not To Spinal Tap, That Is the Question.Retrospective Evaluation of Infants Aged 1 to 60 Days with Residual Cerebrospinal Fluid (CSF) Tested Using the FilmArray Meningitis/Encephalitis (ME) Panel.Changes in trends and impact of testing for influenza in infants with fever <90 days of age.Advancing the Science of Pediatric Antimicrobial Stewardship Beyond Utilization and Direct Costs.Time-to-Positivity of Blood Cultures in Children With Sepsis

P2860

Q30661102-ECE8F8F4-D1C3-4C90-B290-7DA4E3ED76BA Q30998933-C78D77EF-7283-433E-9739-D18582570831 Q31106742-C5ABB1E0-E84D-45F1-846C-2554876A20B2 Q33551790-5843BCD5-F6BA-43BF-A399-B4C1CE04BC49 Q34990668-DA9DC192-E1BF-42E2-A47E-46D04469C119 Q35685079-5C7DB017-1676-4D49-A9F3-41DF1CF71FBF Q36440932-0F53EF9F-2854-47C0-9003-104C37E3030E Q37126300-CF539ED1-DDA5-494F-BDC2-B2B657655960 Q38255594-94AD93E2-662A-4430-9935-395370F430F6 Q38603230-1B9203E3-4757-4AED-A5EC-D687096A8FEB Q38644813-9CEE1BCB-DA97-4FDA-9E69-21491F438B55 Q38775884-3480A8AE-A62D-4AD5-A5EA-B46192AFA4A0 Q38898424-3DCD3A1C-737E-4904-88D5-E985183AE53D Q39188537-FA8802C3-7F7E-4D12-8D7A-D561799CC917 Q39297382-C02C7358-BDDA-41F1-B8B9-FC97C704DB10 Q39318799-B1B4F559-7916-45EF-B195-50B44662F067 Q39448858-13EA0310-E751-476B-B730-0E1FCD083A7B Q40110491-8C2ADE26-3FEF-46C6-9E8D-41C36DA65692 Q40134837-0DEEB3AA-B6BE-44B1-A1A6-689F57AAB994 Q40220653-EBADF25A-EE92-493C-9663-158D9304DBA2 Q40241817-18BE6C7D-611F-4C09-81D9-5A21ED4222A5 Q40889086-13A70756-7247-456F-B123-5B86297B1FA0 Q41928028-F26C0E1E-1856-46B5-B648-C4D0FCCC07DC Q47552227-05B814DF-13C4-43CA-8A91-1816C7C08986 Q50019875-B533433C-73C9-4623-B659-93BB046C4AC7 Q52641874-9809692F-5B62-4B5F-A5A3-16948DE66FE3 Q54233015-874EABD6-9A5F-4774-A6B3-B01E72930326 Q54346507-76A7C9F4-184F-4A86-841B-1C4B431BC069 Q54728342-98B28E79-F2AA-49B7-AF47-7BD37EDD3FE9 Q58795482-7A9213D4-4499-43DF-9476-98E0D59257D8

P2860

Costs and infant outcomes after implementation of a care process model for febrile infants.

http://www.wikidata.org/entity/Q33819465

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Costs and infant outcomes afte ...... ess model for febrile infants.

@ast

Costs and infant outcomes afte ...... ess model for febrile infants.

@en

type

label

Costs and infant outcomes afte ...... ess model for febrile infants.

@ast

Costs and infant outcomes afte ...... ess model for febrile infants.

@en

prefLabel

Costs and infant outcomes afte ...... ess model for febrile infants.

@ast

Costs and infant outcomes afte ...... ess model for febrile infants.

@en

P1433

Q33819465-061C501F-27EC-448D-8052-4E8C6AD69EA8

P1476

Q33819465-8FC5A3AB-CB2C-4B5C-A9D4-492F59191E26

P2093

Q33819465-006859B2-A9BA-40C8-965B-0C94166233B5

Q33819465-691137A9-7FAD-431B-A63F-58671A5D0BBE

Q33819465-7491E0BC-0326-4A19-9235-04C985754422

Q33819465-8981B24E-AEEE-47D9-AE3A-7BA282016AD7

Q33819465-9ACF7341-895A-445C-A645-88A458E46DCE

Q33819465-C63BA5F6-3BBC-472A-BB46-8083115AD783

Q33819465-D52EBDA1-5841-40F4-95AD-75E585910119

Q33819465-D9F4B45D-1EB6-40DE-9513-D362247BA0F8

Q33819465-E3BE16A0-AE18-48A2-8394-4C2BAF743261

Q33819465-E7509022-B503-4E8C-9EBD-7BF4CA05A53C

P2860

Q33819465-0314D0F6-F158-4DC3-9E26-F83F7A0A6BAC

Q33819465-05FC7CBB-776E-422F-8662-DBE6D652224D

Q33819465-06C7133E-2B26-4B50-A1DB-5644C8D2E3D3

Q33819465-07A02776-D20D-4642-A395-11CAB37937D7

Q33819465-0A11F133-AECF-4218-931D-3D3C9237688E

Q33819465-0A4D9E1B-BA25-4B9B-A45B-4A21C3F6C4CF

Q33819465-0ACED0F8-9FEF-46B7-9072-906DCBFF4F06

Q33819465-0BC9D29B-EAC5-4A35-BA5A-C3F53059E6DF

Q33819465-1116445B-CBBE-4D3E-9ABB-464B92CB68D8

Q33819465-14A81F98-D3A2-4E9C-9CA4-970CF1CB9D32

P304

Q33819465-6D788DF6-CC8C-4567-B3BE-64BF15DC52C6

P31

Q33819465-9FAEA14E-0330-4701-AB5F-3919EBE30268

P356

Q33819465-5590083C-CA0C-4DD8-941C-D4321F90EDD5

P407

Q33819465-86BF3863-AA0A-4311-8CD0-7FEA85419BEE

P433

Q33819465-A50817DD-23F9-4419-8884-B24C90A602B9

P478

Q33819465-36C2CDF8-D1FE-40F1-8BC6-FDEC5F42DC85

P50

Q33819465-D9197CCD-1BF6-4083-BA18-4EDE4E0DAC56

P577

Q33819465-B30CFA93-903F-46B8-B7E9-33C54717DBD4

P5875

Q33819465-228E5016-DDB3-4E48-94B5-41DDB11EA613

P698

Q33819465-3F7BE394-63F2-4B82-96AD-9BBF3ED09026

P932

Q33819465-F28A6FCF-0CAA-4BC0-9807-45ACF334A1AD

P356

P1433

P1476

Costs and infant outcomes afte ...... cess model for febrile infants

@en

P2093

Andrew T Pavia

http://www.w3.org/2001/XMLSchema#string

Brent James

http://www.w3.org/2001/XMLSchema#string

Carolyn C Reynolds

http://www.w3.org/2001/XMLSchema#string

Edward B Clark

http://www.w3.org/2001/XMLSchema#string

Judy A Daly

http://www.w3.org/2001/XMLSchema#string

Karen J Valentine

http://www.w3.org/2001/XMLSchema#string

Kent Korgenski

http://www.w3.org/2001/XMLSchema#string

Lucy Savitz

http://www.w3.org/2001/XMLSchema#string

Richard E Nelson

http://www.w3.org/2001/XMLSchema#string

Russell J Osguthorpe

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic testing for serious bacterial infections in infants aged 90 days or younger with bronchiolitis.

Outpatient pediatric blood cultures: time to positivity.

Management of fever without source in infants and children.

Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis.

Normative cerebrospinal fluid profiles in febrile infants.

The effect of rapid respiratory viral diagnostic testing on antibiotic use in a children's hospital.

Utility of sepsis evaluation in infants 90 days of age or younger with fever and clinical bronchiolitis.

Management of the non-toxic-appearing acutely febrile child: a 21st century approach.

Is health care ready for Six Sigma quality?

Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone.

P304

e16-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1542/PEDS.2012-0127

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P50

Carrie Byington

P577

2012-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228065454

http://www.w3.org/2001/XMLSchema#string

P698

22732178

http://www.w3.org/2001/XMLSchema#string

P932

4074609

http://www.w3.org/2001/XMLSchema#string